March
27
TriSalus Life Sciences Reports Q4 and Full Year 2024 Financial Results and Provides Business Update
DENVER–(BUSINESS WIRE)–Mar. 27, 2025– TriSalus Life Sciences Inc., (Nasdaq: TLSI), oncology focused medical technology business...
Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.